To develop criteria for deficiency of essential fatty acids (EFA), we used capillary-column gas-liquid chromatography to determine fatty acids (percentage of total fatty acids) in plasma obtained in the fasting state from 56 reference subjects and from 10 patients with intestinal fat malabsorption and suspected EFA deficiency. The essential fatty acids (EFA)2 linoleic acid (16:2w6) and alpha linolenic acid (18:3w3) cannot be synthesized in the body and must be derived from the diet (1-5). Fatty acids can undergo desaturation and chain-elongation in vivo. The enzymes catalyzing these reactions do not appear to be specific for any given fatty acid family. However, their affinity for these families appears to be in the following decreasing order: w3, w6, w9, and w7 fatty acids (1, 6, 7) .
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To develop criteria for deficiency of essential fatty acids (EFA), we used capillary-column gas-liquid chromatography to determine fatty acids (percentage of total fatty acids) in plasma obtained in the fasting state from 56 reference subjects and from 10 patients with intestinal fat malabsorption and suspected EFA deficiency. Fatty acid evaluations (percentage of total fatty acids) that allowed for a clear distinction (P <0.01) between reference subjects and patients, based on values two standard deviations below or above the reference mean, included values for linoleic acid (18:2w6) below 27%, and values for palmitic acid (16:0), palmitoleic acid (16:1w7), oleic acid (18:1w9), vaccenic acid (18:1w7), and Mead acid (20:3w9) exceeding 21%, 2.6%, 23.3%, 2.1%, and 0.21%, respectively. Ratios of total EFAto total non-EFA of <0.60 and of Mead acid to arachidonic acid of >0.025 also served to identify patients, and were not found in reference subjects. Significant inverse correlations between percentages of plasma EFA and plasma monounsaturated fatty acids were noted. Our reference-interval data can be used to assess normality of plasma EFA status.
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Fatty acids are integral components of cell membranes, and the fatty acid composition of a membrane has profound effects on membrane fluidity and function (1) (2) (3) (4) (5) . Fatty acids are also major constituents of various lipids (phospholipids, triglycerides, and cholesterol esters) within plasma lipoprothin particles, and the role of fatty acids in lipoprotein metabolism is currently under intense investigation (1) (2) (3) (4) (5) . The essential fatty acids (EFA)2 linoleic acid (16:2w6) and alpha linolenic acid (18:3w3) cannot be synthesized in the body and must be derived from the diet (1) (2) (3) (4) (5) . Fatty acids can undergo desaturation and chain-elongation in vivo. The enzymes catalyzing these reactions do not appear to be specific for any given fatty acid family. However, their affinity for these families appears to be in the following decreasing order: w3, w6, w9, and w7 fatty acids (1, 6, 7).
Alpha (11) (12) (13) . Linoleic acid deficiency has been associated with dermatitis, failure to thrive, and inability to reproduce.
EFA deficiency is generally considered to be extremely rare in the general population. However, to our knowledge, reference intervals for plasma fatty acids based on the use of newer, more-sensitive capillary-column gas-liquid chromatography have not been established. Our purpose in this study was to establish such reference intervals and to compare these intervals with values obtained for subjects with intestinal fat malabsorption and suspected EFA deficiency. Our data indicate that the percentages of several fatty acids in plasma clearly differ in these two groups and may be used as indicators ("markers") of EFA deficiency. These reference-interval data can be used to assess dietary requirements for EFA, as well as the EFA requirements of patients who are receiving lipids intravenously.
Materials and Methods

Study Subjects
Blood (20 mL) was collected with EDTA (1 g/L) as anticoagulant, in the fasting state (14 h), from 56 normolipidemic, non-obese subjects (ages 25-65 years; 29 men, 27 women) with no evidence of any chronic illness; and 10 patients (ages 27-51 years, six men, four women) with evidence of intestinal fat malabsorption.
The patients all had required recent parenteral alimentation to meet their nutritional needs, and they had not recently received intravenous lipids. All patients had evidence of inflammatory bowel disease. Many had undergone previous intestinal resection. These patients had suspected EFA deficiency.
Fatty Acid Assay
Plasma samples were stored at -70 #{176}C until extraction.
Lipids were extracted with chloroform:methanol (2/1 by volume) in a ratio of 20:1 for solvent to plasma (10) (11) (12) . detector. Helium was the carrier gas (12) . Column conditions (flow and temperature) were optimized to separate all the peaks of interest, particularly Mead acid, which is often superimposed on 20:2w6 and other peaks.
Peaks were identified by comparison with chromatography of mixtures of authentic fatty and methyl esters. We used a computer/integrator and a DEC VAX 11-780 computer to store the data, integrate and identify peaks, and calculate the percentages and ratios of various fatty acids, as well as the total percentages of fatty acid families. Each chromatogram was reviewed to ensure that all peaks had been properly identified and integrated.
We examined a display of each peak to determine whether any peak baseline was improperly identified by the computer. Improperly integrated peak areas were re-integrated (the area in error was usually <10% of the total peak area) or the sample was re-injected. Minor peaks (including odd-numbered branchchain length and trans fatty acids) separated by the column (12, 16) were not included in the analysis. However, their overall contribution to total peak area was <3%, so their exclusion does not affect the results reported here.
Statistical Analysis
We used non-paired Student's t-test analysis, adjusted for equal or unequal variance, to compare the reference population with the patients, and we performed Pearson correlation coefficient analysis by using the SAS software package (SAS Institute, Cary, NC) on the VAX 11/780 computer. We noted no significant sex-related differences in plasma fatty acids, and therefore the data were combined for men and women in the reference group and patient groups. Table 1 lists the means and standard deviations of the percentages of the total yield of identified fatty acids for the reference subjects and patients. For the essential fatty acids, linoleic and linolenic acid, patients had mean values that were 32% and 66%, respectively, of reference values, while derivatives of these fatty acids such as arachidomc acid and docosahexaenoicacid were 94% and 73% of the reference subjects' values, respectively. Therefore, for these analytes only the percentage as linoleic acid served as a marker of EFA deficiency. The percentage of fatty acid as linolenic acid was too small, and individual variations were too large; making this fatty acid a poor marker of EFA status. From our data, we conclude that a proportion of linoleic acid of less than 27% is more than two standard deviations (2 SD) below the reference mean and suggests the presence of EFA deficiency. Such values were present in all our patients. Totals for the various classes offatty acids are presented in Table 2 . Significantly higher percentages of saturated, w7, and w9 fatty acids (119%, 289%, 170% of reference values) and significantly lower values of w6 and w3 fatty acids (50% and 74%) were seen in patients as compared with reference subjects. These alterations were accompanied by lower total percentages of EFA (51% ofthe reference mean) and higher percentages ofnonessential fatty acids (150%) in patients as compared with controls. Patients with intestinal malabsorption had lower percentages of derivatives of linelenic acid and higher percentages of derivatives of oleic acid in their plasma, with no difference in derivatives of linoleic acid as compared with the reference population. Remarkably, the sum of all these derivatives (derivatives of oleic and alpha-linolenic acids) was very similar in both grOUpS (14.76% in the reference group, 14.86% in the patients).
Results
In terms of the other ratios presented, the ratio of essential fatty acids and derivatives to nonessential fatty acids and derivatives (EFA/non-EFA) provided the best single discriminating variable based on t-test analysis between reference subjects and patients, with values below 0.7 (2 SD below the reference mean) being consistent with EFA deficiency. Another variable that has been reported to be useful in assessing EFA status is the ratio of Mead acid to arachidonic acid. Indeed, patients had ratios that were about 23-fold higher than values for the control population, with values above 0.025 (2 SD above the reference mean) being consistent with EFA deficiency. Carrying out a log transformation on this ratio greatly increases the t value used in assessing the difference between patients and reference subjects (t = 8.1). Other ratios that were significantly increased in the patients as compared with reference subjects.include the ratios of derivatives to precursors for w3, w6, and w9 fatty acid families, the ratio of w3/w6 fatty acids, and the ratio of palmitoleic acid to linoleic acid. These data suggest that patients have an enhanced conversion of precursors to derivatives for various fatty acids, as well as a preservation of w3 fatty acids relative to w6 fatty acids. 
76). Such inverse correlations
were noted in both the reference population and the patients. Novel findings in our study were the striking increase in palmitoleic acid in patients with linoleic acid deficiency and the strong inverse correlation of palmitoleic acid with linoleic acid (see Figure 1 ). An inverse relationship is also clearly present with regard to total mono-unsaturated fatty acids vs total w3 and w6 fatty acids (see Figure 2 ).
Discussion
Previous investigators
have shown that when there are very low proportions of linoleic acid in plasma, there is an increased content of Mead acid in plasma (11-14) . Newer capillary-column gas-liquid chromatographic methods for assay of fatty acids in plasma allow for the more nearly 18: 26 Fig. 1 . Percentages of fatty acids as Iinoleic acid vs palmitoleic acid Closed curbs, reference subjects; triangles,patients. Lober limit percentage of fatty acids as linoleicacid two standarddeviationsbelow the referencemean. Upperlimit percentage offatty acids as paimftoleic acid two standarddeviations abovethe referencemean accurate separation of plasma fatty acids than previous methods (12, 16) . Our purpose here was to utilize this new technology to develop criteria for normal plasma EFA status, using samples obtained in the fasting state from 56 reference subjects and from 10 patients with intestinal fat malabsorption and suspected EFA deficiency.
Reference intervals for the percentages of various plasma fatty acids have been developed based on this reference group (see Table 1 ). These values have been compared with data in subjects with intestinal fat absorption and suspected EFA deficiency. The patients had a significantly lower content of linoleic acid in their plasma and higher contents of palmitic, palmitoleic, oleic, vaccenic, and Mead acid. Our criteria for abnormal values for EFA are based on having #{149}"k.. Table 2 ) were similar for reference subjects and patients. These combined findings are consistent with the view that with increasing deficiency of EFA there is enhanced formation of derivatives of linoleic, linolenic, and oleic acids. Moreover, as plasma EFA deficiency becomes more marked, an increased proportion of mono-unsaturated fatty acids and their derivatives is noted. The body apparently compensates for EFA deficiency in two ways: (a) enhanced conversion of w3, w6, and w9 fatty acids to their derivatives (in order of decreasing efficiency), and (b) accumulation of mono-unsaturated fatty acids. These alterations may take place in EFA deficiency to maintain membrane fluidity. The consequence of this is that EFA deficiency results in more striking increases in Mead acid (a derivative of oleic acid) than in arachidonic acid (a derivative of linoleic acid).
The concentration of Mead acid, a derivative of oleic acid, in plasma and the ratio of Mead acid to arachidonic acid have been identified as markers for EFA deficiency (11) (12) (13) . In summary: utilizing newer methodology, we have developed criteria for assessing EFA status that appear to allow more sensitive and clear-cut detection of plasma EFA abnormalities. The greatly increased difference we found between healthy individuals and patients with evidence of fat malabsorption indicates that we have the potential to detect subjects with even mild EFA deficiency. Such deficiencies may be milder than could previously be detected, and therefore may not be associated with the dermatitis and other abnormalities typical of severe EFA deficiency.
We hope the application of our methodology and criteria for EFA status will allow investigators to determine nutritional requirements for EFA, to more precisely elucidate the relationships between mild EFA deficiency and the factors related to premature cardiovascular disease (e.g., hyperlipidemia, hypertension, and hypercoagulability), and to monitor EFA status in patients who are receiving intravenous nutrition.
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